benign prostatic hyperplasia - Nursing Case Study

Pathophysiology

• Primary mechanism: Hormonal changes, primarily an increase in dihydrotestosterone (DHT) levels, lead to prostate cell proliferation and enlargement. Testosterone is converted to DHT, which binds to androgen receptors, stimulating prostate growth.

• Secondary mechanism: Altered stromal-epithelial interactions within the prostate tissue enhance growth factors and cytokine production, further promoting cellular proliferation and tissue hyperplasia.

• Key complication: Enlarged prostate compresses the urethra, causing urinary obstruction and symptoms such as difficulty urinating, increased frequency, and nocturia, impacting quality of life and potentially leading to bladder dysfunction.

Patient Profile

Demographics:

65-year-old male, retired school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus

• Current medications: Metformin 500 mg twice daily, Lisinopril 10 mg once daily, Tamsulosin 0.4 mg once daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased difficulty urinating and frequent nighttime urination

• Key symptoms: Weak urine stream, sensation of incomplete bladder emptying, occasional urinary incontinence, mild pelvic discomfort

• Vital signs: Blood pressure 145/92 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.7°F

Section 1

Change in Patient Status:

During a follow-up visit, the patient reports worsening urinary symptoms despite adherence to his current medication regimen, which includes Tamsulosin to alleviate urinary obstruction. He now experiences increased urgency and frequency during the day, along with a more pronounced sensation of incomplete bladder emptying. Additionally, he mentions two recent episodes of urinary incontinence during the daytime, which he finds distressing. Upon examination, the patient appears slightly anxious, potentially due to the impact of his symptoms on daily activities and social interactions.

Vital signs remain relatively stable, with blood pressure slightly elevated at 150/94 mmHg, heart rate at 90 bpm, and respiratory rate unchanged at 18 breaths per minute. Physical examination reveals a mildly distended bladder upon palpation, suggesting urinary retention, which may be contributing to his symptoms. A bladder ultrasound confirms post-void residual volume of 250 mL, indicating significant retention. Given these findings, there is concern about potential bladder dysfunction or detrusor muscle instability as a result of chronic obstruction, warranting further evaluation and possible adjustment of his management plan to prevent further complications such as urinary tract infections or renal impairment.

The patient’s recent laboratory results, including kidney function tests, show a slight increase in serum creatinine to 1.4 mg/dL from a previous baseline of 1.2 mg/dL, although still within the upper limit of normal. This change, coupled with the clinical presentation, suggests an evolving condition that requires timely intervention to prevent further kidney damage. Consequently, the healthcare team considers additional therapeutic options, such as combination therapy with a 5-alpha-reductase inhibitor or investigating surgical options like transurethral resection of the prostate (TURP) if pharmacological interventions fail to provide relief.

Section 2

Change in Patient Status

Following the concerning findings from the follow-up visit, the healthcare team decided to initiate combination therapy by adding a 5-alpha-reductase inhibitor, Finasteride, to the patient’s regimen, aiming to reduce the prostate size and further alleviate urinary obstruction. The patient was also scheduled for urodynamic studies to assess bladder function and determine the extent of detrusor muscle instability. In the interim, a urinary catheter was inserted to temporarily relieve the bladder distension and prevent complications from chronic retention.

During a subsequent check-in, the patient reported some initial relief from the catheterization, but still experienced discomfort and persistent urgency. His anxiety persisted, largely driven by the unpredictability of his urinary symptoms and the social embarrassment they caused. Physical examination revealed a soft, non-tender abdomen with a decreased bladder distension. However, the urodynamic studies indicated detrusor overactivity, confirming the suspicion of bladder dysfunction likely due to prolonged obstruction.

In light of these findings and the limited response to pharmacological intervention, the healthcare team discussed potential surgical options with the patient, focusing on the possibility of a TURP procedure to provide more definitive relief. The patient expressed hesitancy but was receptive to considering surgery if his symptoms did not improve with the adjusted medication regimen. The team emphasized the importance of closely monitoring kidney function and urinary symptoms, given the slight rise in creatinine levels, and scheduled regular follow-ups to evaluate the effectiveness of the current management plan and make timely adjustments as needed.

Section 3

Change in Patient Status

Weeks into the revised treatment plan, the patient returned to the clinic with new concerns. Despite initial improvements, he reported a resurgence of urinary urgency and discomfort. His anxiety had worsened, now affecting his sleep and daily activities. In addition to these symptoms, the patient revealed that he had experienced two episodes of nocturnal enuresis, which were distressing and socially embarrassing. Vital signs were stable, with a blood pressure of 128/82 mmHg and a heart rate of 78 bpm. However, a repeat physical examination showed mild suprapubic tenderness, although the bladder was not distended as it had been previously.

Laboratory tests revealed a slight increase in serum creatinine, now at 1.6 mg/dL from a previous 1.4 mg/dL, suggesting worsening kidney function. Urinalysis showed microscopic hematuria and trace proteinuria, raising concerns about potential renal impact due to prolonged urinary obstruction. The combination therapy appeared insufficient in managing his symptoms effectively, and the possibility of acute kidney injury due to obstructive uropathy was considered.

Given these developments, the healthcare team decided to expedite discussions about surgical intervention. The option of a transurethral resection of the prostate (TURP) was revisited, emphasizing the potential for significant symptom relief and the prevention of further renal compromise. The patient, understanding the risks and benefits more clearly, expressed a willingness to proceed with surgery if the current management failed to yield improvements swiftly. The team planned to closely monitor the patient's renal function and symptoms in the interim, reinforcing the need for timely intervention to avert further complications.

Section 4

New Diagnostic Results

In response to the patient's worsening symptoms and concerns about renal function, the healthcare team decided to conduct further diagnostic evaluations. An ultrasound of the kidneys and bladder was performed, revealing mild bilateral hydronephrosis, a clear indication of obstructive uropathy. This finding was consistent with the patient's reported urinary symptoms and the increase in serum creatinine levels. Additionally, a post-void residual measurement demonstrated 150 mL of urine remaining in the bladder after voiding, suggesting incomplete bladder emptying and further supporting the diagnosis of bladder outlet obstruction.

To gain a more comprehensive understanding of the patient's urinary function, a urodynamic study was conducted. The results showed decreased bladder compliance and detrusor overactivity, which were likely contributors to the patient's renewed urgency and episodes of nocturnal enuresis. These findings highlighted the complex interplay between bladder dysfunction and prostatic enlargement, further complicating the clinical picture.

The new diagnostic results underscored the urgency of addressing the underlying obstruction to prevent further renal damage and improve the patient's quality of life. The healthcare team discussed these findings with the patient, reinforcing the importance of surgical intervention. The patient, now more informed about the potential consequences of delaying treatment, expressed a greater sense of urgency regarding the decision to proceed with TURP. As the team prepared for potential surgery, they emphasized the importance of close monitoring and patient education to ensure optimal outcomes.

Section 5

As the healthcare team prepared for the Transurethral Resection of the Prostate (TURP), the patient experienced a change in status that necessitated immediate attention. During a routine assessment, the patient reported increased fatigue and dizziness, prompting the team to conduct a thorough evaluation. Vital signs revealed a blood pressure of 98/62 mmHg, heart rate of 110 bpm, and respiratory rate of 22 breaths per minute. Additionally, laboratory results showed a noticeable decrease in hemoglobin levels, now at 10.5 g/dL compared to 12.8 g/dL from a week prior, indicating a mild anemia that warranted further investigation.

The team considered the possibility of chronic kidney disease exacerbated by prolonged obstructive uropathy, as the mild bilateral hydronephrosis suggested ongoing stress on renal function. The patient's serum creatinine levels had risen slightly since the last measurement, now at 1.8 mg/dL, reinforcing concerns about renal insufficiency. An electrolyte panel revealed a sodium level of 130 mmol/L and potassium level of 5.2 mmol/L, indicating hyponatremia and borderline hyperkalemia, which could contribute to the patient's symptoms and necessitate careful management.

In response to these findings, the healthcare team prioritized stabilizing the patient's hemodynamic status and addressing the electrolyte imbalances. The patient was educated on the importance of adequate hydration and monitoring of dietary intake to manage electrolyte levels. The team initiated a plan to optimize the patient's condition preoperatively, including potential blood transfusion if anemia worsened and close monitoring of renal function. These efforts aimed to mitigate risks and ensure the patient was in the best possible state for the upcoming TURP, emphasizing the importance of comprehensive care in managing both the symptoms and complications of benign prostatic hyperplasia.